Case Reports
 
2022 Feb;13(1):80-84.
 doi: 10.1159/000518629. Epub 2021 Oct 15.

A Novel ATM Gene Mutation Affecting Splicing in an Ataxia-Telangiectasia Patient

Affiliations 

Affiliations

  • 1Department of Medical Genetics, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
  • 2Department of Medical Genetics, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.
  • 3Department of Pediatric Allergy and Immunology, Marmara University School of Medicine, Istanbul, Turkey.
  • 4Department of Medical Genetics, Marmara University School of Medicine, Istanbul, Turkey.
    • PMID: 35221880
 
    • PMCID: PMC8832216 (available on )
 

Abstract

Ataxia-telangiectasia (AT) is an autosomal recessive disorder characterized by progressive ataxia, choreoathetosis and immunodeficiency beginning in early childhood. An 8-year-old girl was referred with a diagnosis of AT. She had gait disturbance and dysarthria for 3years. Multiple cutaneous telangiectases were observed on her face, trunk and limbs. Sequence analysis of the ATM gene revealed a homozygous c.7308-15A>G mutation in IVS49. Human Splicing Finder predicted that the mutation could activate an intronic cryptic acceptor site. We designed primers for amplification of related exons (48-50) from cDNA for evaluating splicing pattern. Sequencing of ATM exons 48-50 revealed a 14-nucleotide insertion from intron 49, between exons 49 and 50, resulting in premature termination of translation at codon 2439. To conclude, we report a novel mutation in a classical AT case, which resulted in an alternatively spliced transcript and was predicted to form a truncated protein or null protein due to nonsense-mediated decay.

Keywords: ATM; Ataxia-telengiectasia syndrome; Novel mutation; Splicing mutation; cDNA sequencing.